News Pfizer looks to M&A after results disappointment Pfizer is looking to deals to keep investors onside after a disappointing set of Q4 results.
News Don't cut prices, cut taxes, pharma CEO tells Trump Industry plays key role in job creation too, says Novartis CEO.
News Pfizer, Novo invest in Swedish patient stratification startu... Funds will go towards development of AMRA's body composition profiling tool AMRA Profiler.
News Pharma project aims to help doctors find drug info Industry giants such as AstraZeneca and Novartis are on board.
News Growth hormone could be filed without further trials, says O... Drug could be filed after "outlier" analysis.
Digital Chaos & opportunity: Dr Adam Brown unpacks US health policy Dive into our video interview with Dr Adam Brown as he unpacks the chaos and opportunity shaping US health policy.
Market Access The value of a partner, globally and locally A new podcast looks at recent trends related to drug approvals, as well as challenges and opportunities both small and large pharma companies face
